These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30536875)

  • 1. Human anti-NKp46 antibody for studies of NKp46-dependent NK cell function and its applications for type 1 diabetes and cancer research.
    Berhani O; Glasner A; Kahlon S; Duev-Cohen A; Yamin R; Horwitz E; Enk J; Moshel O; Varvak A; Porgador A; Jonjic S; Mandelboim O
    Eur J Immunol; 2019 Feb; 49(2):228-241. PubMed ID: 30536875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activating receptor NKp46 is essential for the development of type 1 diabetes.
    Gur C; Porgador A; Elboim M; Gazit R; Mizrahi S; Stern-Ginossar N; Achdout H; Ghadially H; Dor Y; Nir T; Doviner V; Hershkovitz O; Mendelson M; Naparstek Y; Mandelboim O
    Nat Immunol; 2010 Feb; 11(2):121-8. PubMed ID: 20023661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Murine Natural Cytotoxic Receptor NKp46/NCR1 Controls TRAIL Protein Expression in NK Cells and ILC1s.
    Sheppard S; Schuster IS; Andoniou CE; Cocita C; Adejumo T; Kung SKP; Sun JC; Degli-Esposti MA; Guerra N
    Cell Rep; 2018 Mar; 22(13):3385-3392. PubMed ID: 29590608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.
    Glasner A; Ghadially H; Gur C; Stanietsky N; Tsukerman P; Enk J; Mandelboim O
    J Immunol; 2012 Mar; 188(6):2509-15. PubMed ID: 22308311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression.
    Glasner A; Isaacson B; Viukov S; Neuman T; Friedman N; Mandelboim M; Sexl V; Hanna JH; Mandelboim O
    Sci Rep; 2017 Oct; 7(1):13090. PubMed ID: 29026144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46.
    Gur C; Enk J; Kassem SA; Suissa Y; Magenheim J; Stolovich-Rain M; Nir T; Achdout H; Glaser B; Shapiro J; Naparstek Y; Porgador A; Dor Y; Mandelboim O
    J Immunol; 2011 Sep; 187(6):3096-103. PubMed ID: 21849674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.
    Glasner A; Levi A; Enk J; Isaacson B; Viukov S; Orlanski S; Scope A; Neuman T; Enk CD; Hanna JH; Sexl V; Jonjic S; Seliger B; Zitvogel L; Mandelboim O
    Immunity; 2018 Jan; 48(1):107-119.e4. PubMed ID: 29329948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.
    Bar-On Y; Charpak-Amikam Y; Glasner A; Isaacson B; Duev-Cohen A; Tsukerman P; Varvak A; Mandelboim M; Mandelboim O
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
    Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
    J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of the beta cell-derived autoimmune ligand for the killer receptor nkp46 is attenuated in type 2 diabetes.
    Gur C; Enk J; Weitman E; Bachar E; Suissa Y; Cohen G; Schyr RB; Sabanay H; Horwitz E; Glaser B; Dor Y; Pribluda A; Hanna JH; Leibowitz G; Mandelboim O
    PLoS One; 2013; 8(8):e74033. PubMed ID: 24009765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor immunoediting by NKp46.
    Elboim M; Gazit R; Gur C; Ghadially H; Betser-Cohen G; Mandelboim O
    J Immunol; 2010 May; 184(10):5637-44. PubMed ID: 20404273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes.
    Yossef R; Gur C; Shemesh A; Guttman O; Hadad U; Nedvetzki S; Miletić A; Nalbandyan K; Cerwenka A; Jonjic S; Mandelboim O; Porgador A
    PLoS One; 2015; 10(2):e0118936. PubMed ID: 25719382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HIV antibody-dependent activation of NK cells impairs NKp46 expression.
    Parsons MS; Tang CC; Jegaskanda S; Center RJ; Brooks AG; Stratov I; Kent SJ
    J Immunol; 2014 Jan; 192(1):308-15. PubMed ID: 24319263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
    Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
    J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells.
    Sen Santara S; Lee DJ; Crespo Â; Hu JJ; Walker C; Ma X; Zhang Y; Chowdhury S; Meza-Sosa KF; Lewandrowski M; Zhang H; Rowe M; McClelland A; Wu H; Junqueira C; Lieberman J
    Nature; 2023 Apr; 616(7956):348-356. PubMed ID: 37020026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.
    Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP
    Immunity; 2008 Dec; 29(6):958-70. PubMed ID: 19084435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor.
    Narni-Mancinelli E; Chaix J; Fenis A; Kerdiles YM; Yessaad N; Reynders A; Gregoire C; Luche H; Ugolini S; Tomasello E; Walzer T; Vivier E
    Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18324-9. PubMed ID: 22021440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection.
    Diab M; Glasner A; Isaacson B; Bar-On Y; Drori Y; Yamin R; Duev-Cohen A; Danziger O; Zamostiano R; Mandelboim M; Jonjic S; Bacharach E; Mandelboim O
    Eur J Immunol; 2017 Apr; 47(4):692-703. PubMed ID: 28191644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine.
    Luci C; Bekri S; Bihl F; Pini J; Bourdely P; Nouhen K; Malgogne A; Walzer T; Braud VM; Anjuère F
    PLoS One; 2015; 10(12):e0143224. PubMed ID: 26630176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of NKp46
    Haspeslagh E; van Helden MJ; Deswarte K; De Prijck S; van Moorleghem J; Boon L; Hammad H; Vivier E; Lambrecht BN
    EMBO Mol Med; 2018 Apr; 10(4):. PubMed ID: 29444897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.